Legal Representation
Attorney
Stephen Pachol
USPTO Deadlines
Next Deadline
59 days remaining
Non-Final Action E-Mailed - 3-Month Extension Granted (XELG on 2025-12-29)
Due Date
March 26, 2026
Application History
9 events| Date | Code | Type | Description | Documents |
|---|---|---|---|---|
| Dec 29, 2025 | XELG | O | APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED | Loading... |
| Dec 29, 2025 | XELR | I | APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED | Loading... |
| Sep 26, 2025 | GNRN | O | NOTIFICATION OF NON-FINAL ACTION E-MAILED | Loading... |
| Sep 26, 2025 | GNRT | F | NON-FINAL ACTION E-MAILED | Loading... |
| Sep 26, 2025 | CNRT | R | NON-FINAL ACTION WRITTEN | Loading... |
| Sep 22, 2025 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
| Sep 11, 2025 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | Loading... |
| May 2, 2025 | MAFR | O | APPLICATION FILING RECEIPT MAILED | Loading... |
| May 2, 2025 | NWAP | I | NEW APPLICATION ENTERED | Loading... |
Detailed Classifications
Class 035
providing medical information relating to hormonal disorders and pharmaceuticals used to treat endocrine disorders indicated for the treatment of precocious puberty, including patient support services and affordability programs, drug access, and administration guidance
Class 036
providing medical information relating to hormonal disorders and pharmaceuticals used to treat endocrine disorders indicated for the treatment of precocious puberty, including patient support services and affordability programs, drug access, and administration guidance
Class 044
providing medical information relating to hormonal disorders and pharmaceuticals used to treat endocrine disorders indicated for the treatment of precocious puberty, including patient support services and affordability programs, drug access, and administration guidance
Classification
International Classes
035
036
044